LongeVC
Europe, Ticino, Switzerland, Lugano
Description
LongeVC is an early-stage venture firm that focuses on high-impact investments in biotechnology and healthcare.
Investor Profile
LongeVC has backed more than 19 startups, with 4 new investments in the last 12 months alone. The firm has led 5 rounds, about 26% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series A, Series Unknown rounds (top funding stages).
- Majority of deals are located in United States, United Kingdom, Hong Kong.
- Strong thematic focus on Biotechnology, Health Care, Life Science.
- Led 2 rounds in the past year.
Stage Focus
- Seed (42%)
- Series A (37%)
- Series Unknown (16%)
- Pre Seed (5%)
Country Focus
- United States (63%)
- United Kingdom (11%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
- Hong Kong (5%)
'/%3e%3cuse xlink:href='%23a' transform='rotate(144 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(216 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(288 450 300)'/%3e%3c/svg%3e)
- Estonia (5%)
- Switzerland (5%)
- Canada (5%)
Industry Focus
- Biotechnology
- Health Care
- Life Science
- Therapeutics
- Health Diagnostics
- Medical Device
- Artificial Intelligence (Ai)
- Genetics
- Medical
- Information Services
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
